Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NOLAN: Naproxen or Loratadine for Bone Pain in Breast Cancer
NCT01712009Phase 2Completed
- Sponsor
- Amgen
- Start
- Nov 2012
- Primary completion
- Mar 2015
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of naproxen, loratadine in bone pain, sponsored by Amgen. Started Nov 2012; status: completed.
02
Drugs
naproxenloratadine
03
Conditions
bone pain
Beyond the preview
Go deeper on NCT01712009.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01712009.